Constructive Bio
Constructive Bio is a biotechnology company specialising in genome rewriting and synthetic biology to manufacture novel therapeutics.
The UK Home Office lists Constructive Bio as a licensed sponsor (A-rated, Skilled Worker route). They can sponsor work visas. We read every advert and list only roles that don't rule out sponsorship. Home Office figures released under the Freedom of Information Act show Constructive Bio assigned 7 Certificates of Sponsorship in 2021–24 for Skilled Worker and Global Business Mobility visas. We're showing 2 of their current openings.
Sponsor licence details
Sourced from the UK Home Office register of licensed sponsors.
Sponsorship history
Certificates of Sponsorship Constructive Bio assigned each year, from Home Office figures released under the Freedom of Information Act.
Skilled Worker and Global Business Mobility routes. One certificate is assigned for each sponsored hire, visa extension or change of employer, so a person can be counted more than once. “1–5” is withheld by the Home Office; the 2025 figures list only sponsors with 5 or more (“—”). Matched to this employer by its name on the sponsor register. Sources: FOI 2025/12841 (2021–24), FOI2026/03501 (2025). Contains public sector information licensed under the Open Government Licence v3.0.
Licence timeline Pro
Every change we've seen on the Home Office register for Constructive Bio, and what its recent adverts say about sponsorship.
See this employer's full licence history: when it was licensed, rating and route changes, and when it last offered sponsorship in an advert.
Unlock with ProAbout Constructive Bio
Constructive Bio is a biotechnology company operating in the healthcare and life sciences sectors. The company utilises synthetic biology, de-novo genome synthesis, and engineered translation to reprogram genetic codes and develop programmable biomolecules.
Its proprietary BioForge platform integrates genetic code expansion to incorporate non-canonical amino acids into proteins and peptides at precise positions. This technology is used to manufacture metabolic disease treatments, site-specific antibody-drug conjugates, and complex biologics through scalable fermentation in bacterial and mammalian cell lines.
Open roles
2 live positions matched to this sponsor licence.